text.skipToContent text.skipToNavigation

Maximum quantity allowed is 999

Please select the quantity

CAS RN: 27848-84-6 | Product Number: N0904


Purity: >98.0%(T)(HPLC)
  • [(8R,10S)-10-Methoxy-1,6-dimethylergolin-8-yl]methyl 5-Bromopyridine-3-carboxylate
  • 5-Bromopyridine-3-carboxylic Acid [(8R,10S)-10-Methoxy-1,6-dimethylergolin-8-yl]methyl Ester
4   ≥20 
2   Contact Us

*Stock available in Belgium will be delivered in 1 to 3 days
*Stock available in Japan will be delivered in 1 to 2 weeks (excludes regulated items and dry ice shipments).

Product Number N0904
Purity / Analysis Method >98.0%(T)(HPLC)
Molecular Formula / Molecular Weight C__2__4H__2__6BrN__3O__3 = 484.39  
Physical State (20 deg.C) Solid
Storage Temperature <0°C
Condition to Avoid Light Sensitive,Heat Sensitive
CAS RN 27848-84-6
Reaxys Registry Number 903548
PubChem Substance ID 135727224
Merck Index (14) 9496
MDL Number


Appearance White to Light yellow powder to crystal
Purity(HPLC) min. 98.0 area%
Purity(Nonaqueous Titration) min. 98.0 %
Melting point 134.0 to 138.0 °C
Specific rotation [a]20/D +5.2 to +6.2 deg(C=5, EtOH(95vol%))
Properties (reference)
Melting Point 136 °C
Specific Rotation 6.0° (C=5,EtOH(95vol%))
Solubility (soluble in) Ethanol
Pictogram Pictogram
Signal Word Warning
Hazard Statements H302 : Harmful if swallowed.
Precautionary Statements P501 : Dispose of contents/ container to an approved waste disposal plant.
P270 : Do not eat, drink or smoke when using this product.
P264 : Wash skin thoroughly after handling.
P301 + P312 + P330 : IF SWALLOWED: Call a POISON CENTER/doctor if you feel unwell. Rinse mouth.
Related Laws: / Compliance with laws, Regulations
Enzyme Commission 248-694-6
RTECS# KE6341000
Transport Information:
HS Number 2933998090
Pharmacological Studies

Nicergoline inhibits T-type calcium channels in rat isolated hippocampal CA1 pyramidal neurons

K. Takahashi, N. Akaike, Br. J. Pharmacol. 1990, 100, 705.

Modulation of hippocampal ACh release by chronic nicergoline treatment in freely moving young and aged

N. Carfagna, A. D. Clemente, S. Cavanus, D. Damiani, M. Gerna, P. Salmoiraghi, B. Cattaneo, C. Post, Neurosci.

Cholinergic deficits in aged rat brain are corrected with nicergoline

N. Ogawa, M. Asanuma, H. Hirata, Y. Kondo, Y. Kawada, A. Mori, Arch. Gerontology Geriatrics, 1993, 16, 103.

Pharmacological study of nicergoline. Effects on regional cerebral blood flows and arterial carbon dioxide and oxygen pressure and pH in rats under cyanide-induced histotoxic anoxia

K. Shintomi, Arzneim.-Forsch. 1991, 41, 885.

PubMed Literature

Safety Data Sheet (SDS) Search
Please select Language.

The requested SDS is not available.

• Please check that the Product Number you have entered is correct.

• If your information is correct and you are still not able to view the requested SDS,  please Contact Us for more information.

C of A & Other Certificates
Please enter Lot Number Incorrect Lot Number is entered
Other Documents